Author:
Michaeli Daniel T.,Michaeli Thomas
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference50 articles.
1. Overall Survival, Progression-Free Survival, and Tumor Response Benefit Supporting Initial US Food and Drug Administration Approval and Indication Extension of New Cancer Drugs, 2003-2021
2. Cancer Drug Prices in the United States: Efficacy, Innovation;D T Michaeli;Clinical Trial Evidence, and Epidemiology. Value Health,2023
3. Spending For Orphan Indications Among Top-Selling Orphan Drugs Approved To Treat Common Diseases;K P Chua;Health Aff (Millwood),2021
4. FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis;T Michaeli;BMJ,2023